Replies to post #21407 on Marijuana - Companies & Stocks

[DarthYoda]

Actually..."Biden Health Secretary Has Already Talked To FDA About Marijuana Scheduling Review, Which Will Move ‘Quickly’":
October 7, 2022
https://www.marijuanamoment.net/biden-health-secretary-has-already-talked-to-fda-about-marijuana-scheduling-review-which-will-move-quickly/

[DarthYoda]

For what it's worth, it is the Federal Government's own cannabis patent, 6630507, that lead many of us industry vets into the first "pot stocks" a decade ago. If they want rescheduling to move fast now, it will, as they really should have removed it from schedule 1 status as soon as they were assigned that patent. How long do we think it will take the Department of Health and Human Services to review their own patent LOL?...Expired or not, oddly enough, the patent was granted 19 years ago from today...

"Cannabinoids as antioxidants and neuroprotectants":

US-6630507-B1
Publication Date
2003/10/07
Current Assignee
US Department of Health and Human Services
Status
Expired - Lifetime

Abstract
Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. A particular disclosed class of cannabinoids useful as neuroprotective antioxidants is formula (I) wherein the R group is independently selected from the group consisting of H, CH3, and COCH3.

https://patents.google.com/patent/US6630507B1

U.S. Health and Human Services (HHS) Secretary Xavier Becerra said in Tampa Friday that he intends for his agency to move “as quickly as we can” to comply with President Joe Biden’s directive to review the decades-old policy of listing marijuana as a Schedule I drug.

https://www.marijuanamoment.net/biden-health-secretary-has-already-talked-to-fda-about-marijuana-scheduling-review-which-will-move-quickly/